Xconomy | National - Business + Technology in the Exponential Economy

Archives

by in
Entry Blogger Date Location
Elias Zerhouni Talks Public Health Challenges, Culture Wars at WBBA Annual Meeting Gregory T. Huang 11/06/09 Seattle
Gloucester Pharma Wins FDA Approval of Drug for Rare Skin Cancer Luke Timmerman 11/05/09 Boston
Amylin Forms Global Alliance in Obesity Drug Development; TEDMED’s Show Will Go On, Sequenom Sued for Civil Fraud, & More San Diego Biotech News Bruce V. Bigelow 11/05/09 San Diego
Ironwood, Forest Labs Drug for Chronic Constipation Passes Two Pivotal Trials Luke Timmerman 11/03/09 Boston
Combination Drugs Are The Future for Hepatitis C Steve Worland 11/03/09 San Diego
Dendreon Files Provenge Application to FDA Ahead of Schedule, Now It’s Time to Wait Luke Timmerman 11/02/09 Seattle
Amylin Strikes $1 Billion Deal with Takeda to Co-Develop Weight Loss Drugs Luke Timmerman 11/02/09 San Diego
Vertex Hepatitis C Drug Passes Key Test With More Convenient, Twice-Daily Dose Luke Timmerman 10/31/09 Boston
Amylin, Lilly’s Byetta Wins FDA Approval as Standalone Therapy, Without Combo Drugs Luke Timmerman 10/30/09 San Diego
Lilly, With New Focus on Innovation (But Not Necessarily Inclusiveness), Opens San Diego Center for Biotech R&D Bruce V. Bigelow 10/30/09 San Diego
Idenix Shares Drop as Novartis Walks Away From Hepatitis C Drug Luke Timmerman 10/30/09 Boston
ZymoGenetics Rival Emerges, Omeros IPO Casts Shadow, Microsoft’s HealthVault Seeks Users, & More Seattle Area Life Sciences News Luke Timmerman 10/29/09 Seattle
TEDMED Sessions Seek the Patterns in Health Care and Life Sciences That Hold Ideas Together Bruce V. Bigelow 10/28/09 San Diego
Vertex Hepatitis C Drug Wipes Out Virus For Toughest-to-Treat Patients Luke Timmerman 10/28/09 Boston
Sequel Pharmaceuticals’ CEO on How to Start a Biotech and Sell it For a Bundle, and Repeat Luke Timmerman 10/28/09 San Diego
Diabetes drug from San Diego’s Amylin caught up in Aussie Brouhaha Denise Gellene 10/27/09 San Diego
Arena Positions Weight Loss Drug as the One That Won’t Raise Your Blood Pressure Luke Timmerman 10/27/09 San Diego
Burnham Recruits Michael Jackson (No Relation) To Create New Drugs Luke Timmerman 10/26/09 San Diego
Biogen Shares Drop as Tysabri PML Cases Climb to 23, Europe May Seek Drug ‘Holiday’ Luke Timmerman 10/23/09 Boston
Antigenics Shares Plummet as Cancer Vaccine Application Rejected in Europe Luke Timmerman 10/21/09 Boston
Isis CEO Vows that Cholesterol Drug, Partnered With Genzyme, Will be “Remarkable” Advance Luke Timmerman 10/21/09 San Diego
San Diego’s Top 10 Third-Quarter Deals Reveal Slow Comeback in Venture Investing Bruce V. Bigelow 10/20/09 San Diego
Amgen’s Dmab Faces FDA Delay Luke Timmerman 10/19/09 Seattle
Calistoga Cancer Drug Shows “Encouraging” Preliminary Results in Small Study Luke Timmerman 10/19/09 Seattle
Faster, Cheaper Stem Cells: Fate Therapeutics Co-Founder, With Scripps Team, Finds Key Luke Timmerman 10/18/09 National
Eastbourne Dumps Amylin Shares, Illumina Inks Licensing Deal, Avanir Releases Pseudobulbar Affect Data, & More San Diego Life Sciences News Denise Gellene 10/15/09 San Diego
Sirtris Advancing No. 1 Drug into Mid-Stage Clinical Trials for Type 2 Diabetes Ryan McBride 10/14/09 Boston
Alkermes’ Anti-Addiction Drug, Key to Company Pipeline, Passes Early Test Luke Timmerman 10/13/09 Boston
Dendreon Recruits Genentech CEO, Former Lilly Manufacturing Chief to Board Luke Timmerman 10/09/09 Seattle
Amgen’s Seattle and Boston Teams Seek to Boost Biotech Hit Rate 20 to 30 Percent Luke Timmerman 10/09/09 National
Page 1 of 15 next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.